What is the recommended intravenous (IV) dose of Prochlorperazine (Compazine) for nausea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Prochlorperazine (Compazine) can be administered intravenously at a dose of 5-10 mg for acute nausea and vomiting in adults, as recommended by recent guidelines 1. The medication should be given slowly over at least 2 minutes to avoid hypotension.

Key Considerations

  • The maximum daily dose should not exceed 40 mg.
  • For elderly patients, a lower initial dose of 2.5-5 mg is recommended.
  • This medication works by blocking dopamine receptors in the chemoreceptor trigger zone of the brain, which helps control nausea and vomiting.
  • Common side effects include sedation, dizziness, and extrapyramidal symptoms (such as muscle stiffness or tremors).

Monitoring and Precautions

  • Patients should be monitored for hypotension during administration.
  • The medication should be used cautiously in patients with cardiovascular disease, seizure disorders, or those taking other CNS depressants.
  • Diphenhydramine 25-50 mg IV can be administered if extrapyramidal symptoms occur.
  • Compazine should not be used in patients with known hypersensitivity to phenothiazines or those in a comatose state. According to the most recent study 1, Prochlorperazine is listed as a treatment option for nausea and vomiting, with a recommended dose of 5-10 mg qid. Additionally, the NCCN guidelines 1 recommend Prochlorperazine 10 mg PO/IV every 6 h for breakthrough treatment of chemotherapy-induced nausea/vomiting. However, the dose of 5-10 mg IV is more relevant to the treatment of acute nausea and vomiting in adults.

From the FDA Drug Label

TO CONTROL SEVERE NAUSEA AND VOMITING Adjust dosage to the response of the individual. Begin with lowest recommended dosage ... IV Dosage 2.5 mg to 10 mg (0. 5 to 2 mL) by slow IV injection or infusion at a rate not to exceed 5 mg per minute. ADULT SURGERY (FOR SEVERE NAUSEA AND VOMITING) ... IV Dosage 5 mg to 10 mg (1 to 2 mL) as a slow IV injection or infusion 15 to 30 minutes before induction of anesthesia, or to control acute symptoms during or after surgery Repeat once if necessary.

The recommended IV dose of Compazine for nausea is 2.5 mg to 10 mg by slow IV injection or infusion, with a rate not exceeding 5 mg per minute 2. The total IV dosage should not exceed 40 mg per day.

From the Research

Compazine IV Dose for Nausea

  • The studies provided do not directly mention the IV dose of Compazine (prochlorperazine) for nausea 3, 4, 5, 6, 7.
  • However, one study compares the effectiveness of ondansetron and prochlorperazine in treating vomiting and nausea in adults in the emergency department, where prochlorperazine was administered at a dose of 10mg IV 7.
  • Another study mentions that patients given prochlorperazine must be monitored for akathisia that can develop at any time over 48 h post administration, and decreasing the infusion rate can reduce the incidence of this adverse effect 3.
  • It is essential to consult the prescribing information or a healthcare professional for the recommended IV dose of Compazine for nausea.

Antiemetic Agents

  • The studies discuss various antiemetic agents, including droperidol, promethazine, prochlorperazine, metoclopramide, and ondansetron, and their effectiveness in treating nausea and vomiting in different settings 3, 4, 5, 6, 7.
  • Ondansetron is found to be as effective as promethazine and is not associated with sedation or akathisia 3.
  • Metoclopramide and prochlorperazine are also found to be effective in reducing nausea severity, but may have adverse effects such as akathisia and sedation 3, 4, 5, 7.

Related Questions

What is the treatment for severe nausea of unknown etiology?
What is the best anti-nausea medication?
What alternative anti-nausea medication can be used for a patient with Transient Ischemic Attack (TIA) and nausea not controlled with Zofran (ondansetron), who is allergic to Compazine (prochlorperazine)?
Can an 82-year-old female with a history of previous myocardial infarction (PMX) stroke, brain aneurysm, diabetes mellitus (DM), menorrhagia, cholecystectomy, colon polyps, and tubal ligation, who has not responded to Zofran (ondansetron) for nausea, be given an alternative antiemetic medication?
Can Promethazine (Phenergan) and Ondansetron (Zofran) be taken together?
What is Nortriptyline (Pamelor) cream used for?
What is the balance sign in splenic (spleen) injury?
How is the Cholesterol (Chol) to High-Density Lipoprotein (HDL) ratio calculated?
What is the next step in evaluating a 38-year-old man with microscopic hematuria, showing moderate blood on dipstick urinalysis and 10-15 red blood cells (RBC) per high power field (hpf) with over 80% dysmorphic cells?
What are the primary and secondary etiologies, pathophysiology, clinical presentation, laboratory findings, biopsy results (light microscopy, electron microscopy, and immunofluorescence), and treatment options for the following glomerulopathies: Endocapillary (ECM) glomerulonephritis, Focal Segmental Glomerulosclerosis (FSGS), Membranous (Membranous Nephropathy) glomerulopathy, Membranoproliferative (Membranoproliferative Glomerulonephritis) glomerulopathy, and Lupus (Systemic Lupus Erythematosus) glomerulopathy?
What is mesenteric adenitis (inflammation of the mesenteric lymph nodes)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.